LegalFix

217.5403 Eligibility requirements for treatment with investigational drug, biological product, or device.

KY Rev Stat § 217.5403 (2019) (N/A)
Copy with citation
Copy as parenthetical citation

217.5403 Eligibility requirements for treatment with investigational drug, biological product, or device. A patient shall be eligible for treatment with an investigational drug, biological product, or device if the patient has: (1) A terminal illness that is attested to by the patient's treating health care provider; (2) Considered all other treatment options currently approved by the United States Food and Drug Administration; (3) Received a recommendation from the patient's treating health care provider for an investigational drug, biological product, or device; (4) Given written informed consent for the use of the investigational drug, biological product, or device; and (5) Documentation from the treating health care provider that the patient meets the requirements of this section. Effective: June 29, 2017 History: Created 2017 Ky. Acts ch. 65, sec. 3, effective June 29, 2017. Formerly codified as KRS 217.5405.

LegalFix

Copyright ©2024 LegalFix. All rights reserved. LegalFix is not a law firm, is not licensed to practice law, and does not provide legal advice, services, or representation. The information on this website is an overview of the legal plans you can purchase—or that may be provided by your employer as an employee benefit or by your credit union or other membership group as a membership benefit.

LegalFix provides its members with easy access to affordable legal services through a network of independent law firms. LegalFix, its corporate entity, and its officers, directors, employees, agents, and contractors do not provide legal advice, services, or representation—directly or indirectly.

The articles and information on the site are not legal advice and should not be relied upon—they are for information purposes only. You should become a LegalFix member to get legal services from one of our network law firms.

You should not disclose confidential or potentially incriminating information to LegalFix—you should only communicate such information to your network law firm.

The benefits and legal services described in the LegalFix legal plans are not always available in all states or with all plans. See the legal plan Benefit Overview and the more comprehensive legal plan contract during checkout for coverage details in your state.

Use of this website, the purchase of legal plans, and access to the LegalFix networks of law firms are subject to the LegalFix Terms of Service and Privacy Policy.

We have updated our Terms of Service, Privacy Policy, and Disclosures. By continuing to browse this site, you agree to our Terms of Service, Privacy Policy, and Disclosures.
217.5403 Eligibility requirements for treatment with investigational drug, biological product, or device.